DOI: 10.1055/s-00000025

Hormone and Metabolic Research

Referenz

Trump DL, Potter DM, Muindi J, Brufsky A, Johnson CS.
Phase II trial of high-dose, intermittent calcitriol (1, 25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer.

Cancer 2006;
106: 2136-2142

Trump DL, Potter DM, Muindi J, Brufsky A, Johnson CS.
Phase II trial of high-dose, intermittent calcitriol (1, 25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer.

Cancer 2006;
106: 2136-2142

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in:
Aufrufen in: